Condition category
Signs and Symptoms
Date applied
02/08/2004
Date assigned
10/08/2004
Last edited
09/08/2007
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Mr Malcolm Doupe

ORCID ID

Contact details

Primary Health Care Research Unit
St Boniface Research Centre
Winnipeg
Manitoba
R2H 2A6
Canada
mdoupe@sbrc.ca

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Acronym

MAAUI

Study hypothesis

Not provided at time of registration

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

GP practices

Trial type

Quality of life

Patient information sheet

Condition

Chronic pain

Intervention

All primary care physicians in Manitoba, Canada have been randomly assigned to a control group or an intervention study group. The educational intervention being evaluated consists of an audit and feedback mechanism combined with optional participation in a Continuing Medical Education interactive workshop. The primary outcome of the study is the change, from pre- to post- intervention, in physicians' appropriate prescribing of non-steroidal anti-inflammatory therapies for patients requiring chronic treatment. Three classes of non-steroidal anti-inflammatory therapies have been identified: a new class of non-steroidal anti-inflammatory agents known as coxib therapy, traditional non-steroidal anti-inflammatory drug (NSAID) monotherapy, and traditional NSAID therapy combined with gastro-protective agents. Appropriate prescribing is defined based on international clinical practice guidelines and the provincial drug reimbursement policy in Manitoba.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Not provided at time of registration

Secondary outcome measures

Not provided at time of registration

Overall trial start date

01/11/2000

Overall trial end date

01/01/2004

Reason abandoned

Eligibility

Participant inclusion criteria

All primary care physicians in Manitoba, Canada

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

Not provided at time of registration

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

01/11/2000

Recruitment end date

01/01/2004

Locations

Countries of recruitment

Canada

Trial participating centre

Primary Health Care Research Unit
Winnipeg, Manitoba
R2H 2A6
Canada

Sponsor information

Organisation

Merck Frosst Canada and Co. (Canada)

Sponsor details

C.P. 1005
Pointe-Claire-Dorval
Quebec
H9R 4P8
Canada
lorijean_manness@merck.com

Sponsor type

Industry

Website

Funders

Funder type

Industry

Funder name

Merck Frosst Canada Ltd (Canada)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Protocol in: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15327694

Publication citations

  1. Protocol

    Doupe M, Katz A, Kvern B, Manness LJ, Metge C, Thomson GT, Morrison L, Rother K, Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635]., BMC Health Serv Res, 2004, 4, 1, 21, doi: 10.1186/1472-6963-4-21.

Additional files

Editorial Notes